Conor McNamara
Stock Analyst at RBC Capital
(1.29)
# 3,626
Out of 5,058 analysts
141
Total ratings
34.95%
Success rate
-12.44%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $57.81 | +26.28% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.50 | +42.86% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $218.35 | +16.78% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.65 | +81.82% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $86.18 | -46.62% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $74.17 | +17.30% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $11.01 | +54.41% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $120.12 | +4.90% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $304.79 | +34.19% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $303.51 | +34.76% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $155.08 | +31.55% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $573.79 | +11.02% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $222.41 | +12.41% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $20.99 | +190.61% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.01 | +74.56% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $57.81
Upside: +26.28%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.50
Upside: +42.86%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $218.35
Upside: +16.78%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.65
Upside: +81.82%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $86.18
Upside: -46.62%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $74.17
Upside: +17.30%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $11.01
Upside: +54.41%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $120.12
Upside: +4.90%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $304.79
Upside: +34.19%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $303.51
Upside: +34.76%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $155.08
Upside: +31.55%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $573.79
Upside: +11.02%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $222.41
Upside: +12.41%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $20.99
Upside: +190.61%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.01
Upside: +74.56%